Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 2 (February)

1. Cancer-associated stromal fibroblasts promote pancreatic tumor progression.
   Cancer Res, 68(3): 918-26. [Abstract] [Full-text]
2. The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.
   Future Oncol, 4(1): 41-50. [Abstract] [Full-text]
3. CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.
   Lancet Oncol, 9(2): 132-8. [Abstract] [Full-text]
4. Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.
   Gut, 57(3): 344-51. [Abstract] [Full-text]
5. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
   Gut, 57(3): 339-43. [Abstract] [Full-text]
6. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
   J Clin Oncol, 26(6): 942-7. [Abstract] [Full-text]
7. Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers.
   Cancer Res, 68(4): 971-5. [Abstract] [Full-text]
8. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.
   J Surg Res, 145(1): 111-23. [Abstract] [Full-text]
9. Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy.
   Br J Surg, 95(3): 357-62. [Abstract] [Full-text]
10. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
    Gynecol Oncol, 108(3): 515-9. [Abstract] [Full-text]
11. Type IV collagen alpha6 chain-derived noncollagenous domain 1 (alpha6(IV)NC1) inhibits angiogenesis and tumor growth.
    Int J Cancer, 122(8): 1738-44. [Abstract] [Full-text]
12. Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression.
    J Cell Physiol, 215(2): 401-9. [Abstract] [Full-text]
13. Macrocystic serous cystadenocarcinoma of the pancreas: the first report of a new pattern of pancreatic carcinoma.
    J Clin Pathol, 61(3): 396-8. [Abstract] [Full-text]
14. Pancreatic incidentalomas: clinical and pathologic spectrum.
    Am J Surg, 195(3): 329-32; discussion 332. [Abstract] [Full-text]
15. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Am J Surg, 195(3): 318-21. [Abstract] [Full-text]
16. Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinoma.
    Am J Surg, 195(3): 308-11; discussion 312. [Abstract] [Full-text]
17. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
    J Am Coll Surg, 206(3): 451-7. [Abstract] [Full-text]
18. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
    J Am Coll Surg, 206(3): 445-50. [Abstract] [Full-text]
19. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort.
    Am J Epidemiol, 167(5): 586-97. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.